{"id":"lexiscan","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Dyspnea","drugRate":"","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"","severity":"common","organSystem":""},{"effect":"Chest pain","drugRate":"","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"","severity":"common","organSystem":""},{"effect":"Palpitations","drugRate":"","severity":"common","organSystem":""},{"effect":"Flushing","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Wheezing","drugRate":"","severity":"common","organSystem":""},{"effect":"Tachycardia","drugRate":"","severity":"common","organSystem":""},{"effect":"Arrhythmia","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Acute cerebrovascular insufficiency","Aortic valve stenosis","Asthma","Bradycardia","Bronchospasm","Carotid artery stenosis","Chronic obstructive lung disease","Complete atrioventricular block","Disorder of autonomic nervous system","Hypertensive disorder","Hypovolemia","Left main coronary artery disease","Low blood pressure","Mitral valve stenosis","Pericardial effusion","Pericarditis","Second degree atrioventricular block","Seizure disorder","Sick sinus syndrome","Sinus bradycardia","Syncope","Transient ischemic attack","Wheezing"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Myocardial Ischemia","drugRate":"","severity":"serious"},{"effect":"Sinoatrial and Atrioventricular Nodal Block","drugRate":"","severity":"serious"},{"effect":"Atrial Fibrillation/Atrial Flutter","drugRate":"","severity":"serious"},{"effect":"Anaphylaxis","drugRate":"","severity":"serious"},{"effect":"Hypotension","drugRate":"","severity":"serious"},{"effect":"Hypertension","drugRate":"","severity":"serious"},{"effect":"Bronchoconstriction","drugRate":"","severity":"serious"},{"effect":"Seizure","drugRate":"","severity":"serious"},{"effect":"Cerebrovascular Accident (Stroke)","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":null,"aliases":["Regadenoson"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"99640071-4db2-9317-e053-2995a90a610d","title":"LEXISCAN(R) (REGADENOSON) INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]"},"ecosystem":[],"mechanism":{"target":"Adenosine receptor A3, Adenosine receptor A1, Adenosine receptor A2a"},"_scrapedAt":"2026-03-28T02:42:26.440Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Myocardial Perfusion Imaging Adjunct","diseaseId":"myocardial-perfusion-imaging-adjunct","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06854458","phase":"NA","title":"The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-06-27","conditions":"Ischemic Heart Disease (IHD), Cardiac Magnetic Resonance Imaging, Myocardial Blood Flow","enrollment":1000},{"nctId":"NCT03331380","phase":"NA","title":"Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2018-01-05","conditions":"CAD","enrollment":2950},{"nctId":"NCT06814587","phase":"","title":"Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-07-01","conditions":"Coronary Artery Disease, Coronary Artery Bypass Graft (CABG)","enrollment":15},{"nctId":"NCT03505736","phase":"","title":"Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2018-06-21","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8","enrollment":25},{"nctId":"NCT04316676","phase":"NA","title":"The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI","status":"COMPLETED","sponsor":"Emory University","startDate":"2021-06-16","conditions":"Coronary Artery Disease","enrollment":20},{"nctId":"NCT05583721","phase":"PHASE2","title":"Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2023-10-10","conditions":"Sickle Cell Disease","enrollment":40},{"nctId":"NCT04604782","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients","status":"RECRUITING","sponsor":"GE Healthcare","startDate":"2021-05-20","conditions":"Myocardial Ischemia, Coronary Artery Disease","enrollment":54},{"nctId":"NCT01719016","phase":"","title":"Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cincinnati","startDate":"2010-08","conditions":"Coronary Artery Disease","enrollment":68},{"nctId":"NCT06246188","phase":"","title":"Use of Stress-CMR Using Regadenoson and GE-267 in Adult Patients with Known or Suspected Coronary Artery Disease","status":"NOT_YET_RECRUITING","sponsor":"German Heart Institute","startDate":"2025-06-01","conditions":"Coronary Artery Disease","enrollment":80},{"nctId":"NCT04606069","phase":"PHASE1, PHASE2","title":"Treat COVID-19 Patients With Regadenoson","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2021-05-06","conditions":"COVID-19, Lung Inflammation","enrollment":5},{"nctId":"NCT03102125","phase":"PHASE4","title":"Allograft Dysfunction in Heart Transplant","status":"RECRUITING","sponsor":"Paul Kim","startDate":"2019-10-01","conditions":"Heart Transplant Failure and Rejection","enrollment":376},{"nctId":"NCT00837369","phase":"PHASE1","title":"Regadenoson R-T Perfusion Imaging Trial","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2009-04-07","conditions":"Coronary Artery Disease, Myocardial Perfusion Abnormalities","enrollment":100},{"nctId":"NCT06735521","phase":"","title":"Cardiac Magnetic Resonance Stress-perfusion Study in Patinets with Fontan Circulation","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2024-04-15","conditions":"Univentricular Heart, Microvascular Dysfunction, Heart Failure","enrollment":30},{"nctId":"NCT01334918","phase":"PHASE2","title":"A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2011-04-26","conditions":"Coronary Artery Disease (CAD)","enrollment":124},{"nctId":"NCT00826280","phase":"PHASE3","title":"Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-03-24","conditions":"Coronary Artery Disease (CAD)","enrollment":347},{"nctId":"NCT01489176","phase":"PHASE3","title":"Regadenoson Real Time Perfusion Imaging Trial-Optison","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2012-07-31","conditions":"Coronary Artery Disease, Myocardial Perfusion Abnormalities","enrollment":50},{"nctId":"NCT02130453","phase":"PHASE4","title":"Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-09-30","conditions":"Ischemia","enrollment":161},{"nctId":"NCT04521569","phase":"EARLY_PHASE1","title":"Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2020-06-22","conditions":"Lung Transplant","enrollment":47},{"nctId":"NCT01566890","phase":"NA","title":"Microvascular Blood Flow in Sickle Cell Anemia","status":"COMPLETED","sponsor":"Versiti Blood Health","startDate":"2012-07","conditions":"Sickle Cell Disease, Sickle Cell Anemia","enrollment":91},{"nctId":"NCT04465526","phase":"","title":"The Influence of Coronary Chronic Total Occlusion on Myocardial Perfusion on Computed Tomography","status":"COMPLETED","sponsor":"National Institute of Cardiology, Warsaw, Poland","startDate":"2020-02-01","conditions":"Coronary Occlusion, Myocardial Ischemia, Myocardial Perfusion Imaging","enrollment":27},{"nctId":"NCT03971734","phase":"PHASE1","title":"Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2019-12-06","conditions":"High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma","enrollment":7},{"nctId":"NCT03354273","phase":"PHASE3","title":"An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2018-06-05","conditions":"Coronary Artery Disease (CAD)","enrollment":730},{"nctId":"NCT05813210","phase":"NA","title":"Myocardial Ischemia Detection With a Combined Cardiovascular Magnetic Resonance and Biomarker Protocol","status":"NOT_YET_RECRUITING","sponsor":"Kantonsspital Olten","startDate":"2023-05-01","conditions":"Myocardial Ischemia Demand","enrollment":772},{"nctId":"NCT01250496","phase":"PHASE4","title":"Study With Aminophylline to Attenuate of the Side Effects of Regadenoson","status":"TERMINATED","sponsor":"Rush University Medical Center","startDate":"2010-11","conditions":"Patients Being Assessed With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson, Lexiscan","enrollment":248},{"nctId":"NCT03064295","phase":"","title":"Whole-Heart Myocardial Blood Flow Quantification Using MRI","status":"UNKNOWN","sponsor":"Cedars-Sinai Medical Center","startDate":"2018-03-01","conditions":"Coronary Artery Disease, Coronary Microvascular Disease","enrollment":160},{"nctId":"NCT01336140","phase":"PHASE4","title":"Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2011-06","conditions":"Patients With Severe Chronic Kidney Disease Being Evaluated With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson","enrollment":300},{"nctId":"NCT03800862","phase":"","title":"The Evaluation of the Roles of New Cardiac Imaging in Patients With Chest Pain","status":"TERMINATED","sponsor":"Lancaster General Hospital","startDate":"2019-03-27","conditions":"Cardiology, Radiology, Stenoses","enrollment":14},{"nctId":"NCT01842035","phase":"NA","title":"Heart Rate Response to Regadenoson and Sudden Cardiac Death","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2013-02","conditions":"Left Ventricular Systolic Dysfunction, Sudden Cardiac Death","enrollment":90},{"nctId":"NCT01026012","phase":"NA","title":"Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2009-12","conditions":"Cardiac Function","enrollment":40},{"nctId":"NCT03338504","phase":"","title":"Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2017-10-23","conditions":"Myocardial Infarction, Acute, Myocardial Ischemia, Myocardial Injury","enrollment":100},{"nctId":"NCT03236311","phase":"PHASE2","title":"A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI","status":"TERMINATED","sponsor":"Sanofi","startDate":"2017-10-12","conditions":"Microvascular Coronary Artery Disease","enrollment":10},{"nctId":"NCT01044901","phase":"","title":"Cardiovascular Complications of Sickle Cell Disease","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2009-03","conditions":"Sickle Cell Disease","enrollment":51},{"nctId":"NCT03449888","phase":"","title":"Arm Exercise Versus Pharmacologic Stress Testing for Clinical Outcome","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2018-07-01","conditions":"Veterans Referred to the St. Louis VAMC Stress Tes","enrollment":133},{"nctId":"NCT02749045","phase":"NA","title":"Simultaneous Assessment of FFR and SPECT","status":"TERMINATED","sponsor":"Prem Soman","startDate":"2016-07","conditions":"Coronary Artery Disease","enrollment":27},{"nctId":"NCT03170817","phase":"","title":"Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT","status":"COMPLETED","sponsor":"Stanford University","startDate":"2017-03-29","conditions":"Coronary Artery Disease","enrollment":15},{"nctId":"NCT05081115","phase":"","title":"Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging","status":"RECRUITING","sponsor":"Fatebenefratelli Hospital","startDate":"2021-04-01","conditions":"Coronary Artery Disease, Heart Failure, Hypertrophic Cardiomyopathy","enrollment":10000},{"nctId":"NCT01655524","phase":"PHASE4","title":"The Impact of the Routine Aminophylline Administration Following Regadenoson Stress on SPECT Myocardial Perfusion","status":"WITHDRAWN","sponsor":"Rush University Medical Center","startDate":"2012-07","conditions":"Coronary Artery Disease","enrollment":""},{"nctId":"NCT00871260","phase":"PHASE4","title":"Stress Testing and Cardiac Magnetic Resonance","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2009-04","conditions":"Coronary Disease","enrollment":20},{"nctId":"NCT01969916","phase":"NA","title":"Stress CT Perfusion in Patients With Chest Pain","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2014-06","conditions":"Coronary Artery Disease","enrollment":150},{"nctId":"NCT02589977","phase":"PHASE4","title":"Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF","status":"COMPLETED","sponsor":"Marvin W. Kronenberg, M.D.","startDate":"2015-11","conditions":"Heart Failure, Diastolic, Diastolic Heart Failure, Hypertension","enrollment":55},{"nctId":"NCT02220634","phase":"NA","title":"Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension","status":"TERMINATED","sponsor":"National Jewish Health","startDate":"2014-08","conditions":"Pulmonary Hypertension","enrollment":10},{"nctId":"NCT04600115","phase":"EARLY_PHASE1","title":"New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)","status":"UNKNOWN","sponsor":"University of Utah","startDate":"2017-03-03","conditions":"MRI Scans","enrollment":100},{"nctId":"NCT03249272","phase":"PHASE4","title":"Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve","status":"TERMINATED","sponsor":"Duke University","startDate":"2017-09-05","conditions":"Hypertrophic Cardiomyopathy, Non-ischemic Dilated Cardiomyopathy, Microvascular Ischaemia of Myocardium","enrollment":31},{"nctId":"NCT02608944","phase":"NA","title":"Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging","status":"WITHDRAWN","sponsor":"University of Utah","startDate":"2012-09-30","conditions":"MRI Scans","enrollment":""},{"nctId":"NCT04475094","phase":"","title":"Impact of Coronary Artery Stenting on Quantitative Myocardial Blood Flow and Health Status","status":"UNKNOWN","sponsor":"Cardiovascular Imaging Technologies","startDate":"2019-12-23","conditions":"Coronary Artery Disease","enrollment":75},{"nctId":"NCT03072589","phase":"PHASE1","title":"Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation","status":"UNKNOWN","sponsor":"Christine Lau, MD","startDate":"2017-11-30","conditions":"Lung Transplant","enrollment":21},{"nctId":"NCT02697877","phase":"","title":"Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2016-02","conditions":"Coronary Artery Disease","enrollment":183},{"nctId":"NCT03917199","phase":"","title":"Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).","status":"COMPLETED","sponsor":"National Institute of Cardiology, Warsaw, Poland","startDate":"2016-11","conditions":"Myocardial Perfusion Imaging, Computed Tomography, Coronary Artery Disease","enrollment":60},{"nctId":"NCT01518777","phase":"NA","title":"Reducing Radioisotope Dose: the Half-Dose CZT Study","status":"COMPLETED","sponsor":"S.M.Chang, MD","startDate":"2012-01","conditions":"Coronary Artery Disease","enrollment":74},{"nctId":"NCT01655043","phase":"PHASE2","title":"Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2012-09","conditions":"Myocardial Ischemia","enrollment":20},{"nctId":"NCT03103061","phase":"PHASE2","title":"Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2016-02-09","conditions":"Cardiovascular Diseases, Coronary Artery Disease","enrollment":24},{"nctId":"NCT03976921","phase":"NA","title":"Impact of Stress CT Myocardial Perfusion on Downstream Resources and Prognosis","status":"UNKNOWN","sponsor":"Centro Cardiologico Monzino","startDate":"2019-06-01","conditions":"Coronary Artery Disease, Myocardial Ischemia","enrollment":2000},{"nctId":"NCT02560467","phase":"NA","title":"Perfusion Imaging With Myocardial Contrast Echocardiography in HCM","status":"UNKNOWN","sponsor":"Oregon Health and Science University","startDate":"2015-12-01","conditions":"Hypertrophic Cardiomyopathy","enrollment":10},{"nctId":"NCT03101696","phase":"","title":"Determination of Coronarphysiological Parameters With the Method of Thermodillution","status":"COMPLETED","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2017-02-05","conditions":"Coronary Artery Stenosis of Unclear Hemodynamic Relevance","enrollment":50},{"nctId":"NCT01433705","phase":"PHASE1","title":"Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal Volunteers","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2011-11","conditions":"Heart Disease","enrollment":70},{"nctId":"NCT02389738","phase":"EARLY_PHASE1","title":"Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2015-02","conditions":"Blood Brain Barrier Defect","enrollment":6},{"nctId":"NCT01109992","phase":"PHASE4","title":"Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2011-02","conditions":"Coronary Artery Disease","enrollment":43},{"nctId":"NCT00763035","phase":"EARLY_PHASE1","title":"Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2009-01","conditions":"Coronary Artery Disease, Asthma, Chronic Obstructive Pulmonary Disease (COPD)","enrollment":14},{"nctId":"NCT02115308","phase":"PHASE4","title":"Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"Timothy M. Bateman","startDate":"2014-09-03","conditions":"Coronary Artery Disease","enrollment":40},{"nctId":"NCT01949844","phase":"NA","title":"Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies","status":"COMPLETED","sponsor":"Daniel S. Berman","startDate":"2014-05-16","conditions":"Coronary Artery Disease, CAD","enrollment":44},{"nctId":"NCT01919450","phase":"PHASE4","title":"Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation","status":"COMPLETED","sponsor":"Timothy M. Bateman, MD","startDate":"2013-07","conditions":"Myocardial Blood Flow Reserve","enrollment":80},{"nctId":"NCT01779869","phase":"PHASE4","title":"Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2013-01","conditions":"Ischemic Heart Disease","enrollment":16},{"nctId":"NCT01482169","phase":"NA","title":"Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)","status":"COMPLETED","sponsor":"Ochsner Health System","startDate":"2012-03","conditions":"Coronary Artery Disease","enrollment":48},{"nctId":"NCT03084562","phase":"","title":"Regadenoson vs Dipyridamole in Use as Pharmacological Stress Agent Before SPECT","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2017-05-03","conditions":"Myocardial Perfusion Imaging","enrollment":300},{"nctId":"NCT02092428","phase":"PHASE1","title":"Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2011-04","conditions":"Coronary Artery Disease","enrollment":333},{"nctId":"NCT01788631","phase":"PHASE2","title":"A Phase II Trial of Regadenoson in Sickle Cell Anemia","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2013-07","conditions":"Sickle Cell Anemia","enrollment":100},{"nctId":"NCT01710254","phase":"PHASE2","title":"Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients","status":"COMPLETED","sponsor":"University of Utah","startDate":"2013-01","conditions":"Atrial Fibrillation, Coronary Artery Disease","enrollment":30},{"nctId":"NCT01446094","phase":"PHASE4","title":"Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease","status":"UNKNOWN","sponsor":"Dipan Shah","startDate":"2011-08","conditions":"Coronary Artery Disease","enrollment":50},{"nctId":"NCT02597543","phase":"PHASE4","title":"Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction","status":"COMPLETED","sponsor":"Paul Kim","startDate":"2015-11","conditions":"Heart Transplant, Acute Graft Rejection, Chronic Graft Rejection","enrollment":14},{"nctId":"NCT01161121","phase":"PHASE1","title":"Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia","status":"COMPLETED","sponsor":"St. Louis University","startDate":"2010-07","conditions":"Coronary Artery Disease","enrollment":46},{"nctId":"NCT02628002","phase":"NA","title":"Anti-gravity Treadmill Exercise in Stress Myocardial Perfusion Imaging","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2015-12","conditions":"Coronary Artery Disease","enrollment":49},{"nctId":"NCT03090087","phase":"PHASE2","title":"The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo","status":"UNKNOWN","sponsor":"University of Aarhus","startDate":"2017-03-22","conditions":"Retinal Artery Occlusion","enrollment":20},{"nctId":"NCT00857792","phase":"NA","title":"Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2009-03","conditions":"Coronary Disease","enrollment":120},{"nctId":"NCT01618669","phase":"PHASE3","title":"A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2012-06","conditions":"Coronary Artery Disease (CAD)","enrollment":1147},{"nctId":"NCT01019486","phase":"PHASE4","title":"Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2009-11","conditions":"Coronary Artery Disease, Type 1 Diabetes Mellitus","enrollment":26},{"nctId":"NCT01150578","phase":"","title":"Evaluation of Myocardial Ischemia Using Standard Single Photon Emission Computed Tomography (SPECT) With Regadenoson and Simultaneous Cardiac Echocardiography","status":"UNKNOWN","sponsor":"Aiden Abidov","startDate":"2011-12","conditions":"Myocardial Ischemia","enrollment":380},{"nctId":"NCT01697995","phase":"","title":"Stress Induced Right Ventricular Uptake on Lexiscan Stress MPI","status":"UNKNOWN","sponsor":"Aiden Abidov","startDate":"2013-01","conditions":"Increased Right Ventricular Radiotracer Uptake","enrollment":650},{"nctId":"NCT01021865","phase":"","title":"Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2010-02","conditions":"Coronary Artery Disease, Diabetes Mellitus Type 2","enrollment":33},{"nctId":"NCT01840696","phase":"PHASE2","title":"Phase Analysis and Obstructive CAD on Rubidium PET","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2013-10","conditions":"Coronary Artery Disease","enrollment":""},{"nctId":"NCT01085201","phase":"PHASE1","title":"Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2010-04","conditions":"Sickle Cell Disease","enrollment":39},{"nctId":"NCT00907764","phase":"PHASE2","title":"Stress Echocardiography Study With Regadenoson","status":"TERMINATED","sponsor":"Gilead Sciences","startDate":"2009-04","conditions":"Heart Disease, Coronary Artery Disease","enrollment":22},{"nctId":"NCT01809743","phase":"PHASE3","title":"Regadenoson and Adenosine","status":"COMPLETED","sponsor":"Lokien van Nunen","startDate":"2013-01","conditions":"Coronary Artery Disease","enrollment":100},{"nctId":"NCT01370265","phase":"NA","title":"Myocardial Blood Flow by PET and N-13 Ammonia During Regadenoson vs Adenosine Stress","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2011-02","conditions":"Coronary Artery Disease","enrollment":12},{"nctId":"NCT01918995","phase":"PHASE1","title":"Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2013-05","conditions":"Healthy Volunteers","enrollment":36},{"nctId":"NCT01778218","phase":"PHASE2","title":"A Single Center Study to Establish the Imaging Protocol of 99mTc-EC-DG in Evaluating the Presence and Severity of Coronary Artery Disease (CAD)","status":"COMPLETED","sponsor":"Cell>Point LLC","startDate":"2013-01","conditions":"Coronary Artery Disease","enrollment":2},{"nctId":"NCT01021618","phase":"NA","title":"Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2010-01","conditions":"Coronary Artery Disease, Myocardial Ischemia","enrollment":140},{"nctId":"NCT00862641","phase":"PHASE4","title":"A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-04","conditions":"Asthma, Coronary Artery Disease, Pulmonary Disease, Chronic Obstructive","enrollment":1009},{"nctId":"NCT00808314","phase":"PHASE4","title":"Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress","status":"UNKNOWN","sponsor":"Cardiovascular Imaging Technologies","startDate":"2008-12","conditions":"Coronary Artery Disease","enrollment":32},{"nctId":"NCT00863707","phase":"PHASE4","title":"A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-04","conditions":"Kidney Diseases, Coronary Artery Disease","enrollment":511},{"nctId":"NCT00881218","phase":"EARLY_PHASE1","title":"Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2009-06","conditions":"Ischemic Heart Disease","enrollment":50},{"nctId":"NCT00894179","phase":"","title":"Safety and Accuracy Study of Regadenoson Atropine Combination for Stress Echocardiography in Identification of Coronary Artery Disease","status":"UNKNOWN","sponsor":"Henry Ford Health System","startDate":"2009-05","conditions":"Coronary Artery Disease","enrollment":110},{"nctId":"NCT00797186","phase":"NA","title":"Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2008-11","conditions":"Type 2 Diabetes, Microvascular Dysfunction","enrollment":150},{"nctId":"NCT00859833","phase":"NA","title":"Effects of Body Mass Index on the Hyperemic Response to Regadenoson","status":"COMPLETED","sponsor":"University of Utah","startDate":"2009-02","conditions":"Obesity, Endothelial Dysfunction, Decreased Vascular Flow","enrollment":30},{"nctId":"NCT00208299","phase":"PHASE3","title":"ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2003-10","conditions":"Coronary Artery Disease","enrollment":1231},{"nctId":"NCT00208312","phase":"PHASE3","title":"ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2004-04","conditions":"Coronary Artery Disease","enrollment":787},{"nctId":"NCT00846079","phase":"PHASE3","title":"Myocardial Perfusion Assessment With Multidetector Computed Tomography","status":"UNKNOWN","sponsor":"Tennessee Heart and Vascular Institute, P.C.","startDate":"2009-02","conditions":"Coronary Artery Disease","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[{"date":"20080410","type":"ORIG","sponsor":"ASTELLAS","applicationNumber":"NDA022161"},{"date":"20140919","type":"SUPPL","sponsor":"ASTELLAS","applicationNumber":"NDA022161"},{"date":"20110930","type":"SUPPL","sponsor":"ASTELLAS","applicationNumber":"NDA022161"},{"date":"20110923","type":"SUPPL","sponsor":"ASTELLAS","applicationNumber":"NDA022161"},{"date":"20140329","type":"SUPPL","sponsor":"ASTELLAS","applicationNumber":"NDA022161"},{"date":"20090317","type":"SUPPL","sponsor":"ASTELLAS","applicationNumber":"NDA022161"},{"date":"20180531","type":"SUPPL","sponsor":"ASTELLAS","applicationNumber":"NDA022161"},{"date":"20170117","type":"SUPPL","sponsor":"ASTELLAS","applicationNumber":"NDA022161"},{"date":"20140109","type":"SUPPL","sponsor":"ASTELLAS","applicationNumber":"NDA022161"},{"date":"20110923","type":"SUPPL","sponsor":"ASTELLAS","applicationNumber":"NDA022161"},{"date":"20110923","type":"SUPPL","sponsor":"ASTELLAS","applicationNumber":"NDA022161"},{"date":"20091223","type":"SUPPL","sponsor":"ASTELLAS","applicationNumber":"NDA022161"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":27,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Lexiscan","genericName":"Lexiscan","companyName":"Medical University of South Carolina","companyId":"medical-university-of-south-carolina","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":3,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}